Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral PTH(1-34) vs NATPARA in Hypoparathyroidism
NCT03516773Phase 2Completed
- Sponsor
- Entera Bio Ltd.
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of EBP11 in hypoparathyroidism, sponsored by Entera Bio Ltd.. Started Jun 2018; status: completed.
02
Drugs
EBP11
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT03516773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516773.